About HORUS
The intelligence layer
for acute stroke.
HORUS NeuroTechnologies is a University of Pittsburgh licensed company. We build the systems that close the gaps between stages of stroke care, so the evidence the field already has reaches every patient, at every center, every time.
A clinical intelligence company for acute stroke.
Founded by a vascular and interventional neurology team, and researchers who know code strokes to the core, HORUS turns the evidence the field already has into decisions that reach every patient.
Our systems read the clinical picture in real time and return guideline-graded, personalized decisions at the moment they matter, from the first call to follow-up.
Meet the teamBuilt by the NeuroPrecision Lab.
HORUS systems are designed and validated at the NeuroPrecision Lab, where stroke physicians and researchers work on personalized decisions for acute stroke care.
neuroprecisionlab.orgLicensed by the University of Pittsburgh.
An exclusive, worldwide software license covering LUCID and TrialLens, effective May 26, 2026, moving both systems from the research bench toward clinical deployment.
University of PittsburghDifferent tools, different jobs.
Detection finds the clot and prediction scores the risk. Neither makes the guideline-graded treatment decision, and general language models cannot make it reliably.
| Capability | Detection | Prediction | Language models | HORUS |
|---|---|---|---|---|
| Guideline-graded treatment decision | Different task | Different task | No | Yes |
| Class and level of evidence on every answer | Different task | Different task | Unreliable (41 to 53%) | Yes |
| Same case, same answer, every time | Different task | Different task | No | Yes |
| Tested against the full guideline | Different task | Different task | 71 to 78% | 100% |
Language-model figures are from the HORUS benchmark.
Talk to the founding team.
For clinical demonstrations, validation data or partnership, reach us directly at horusneurotechnologies@gmail.com.
News and milestonesSee LUCID on your own cases.
A 30-minute walkthrough with the team that built it.